| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | ADORA2A ADRA1A GPR19 OR6B3 OR1I1 APLNR OR2C3 ADGRV1 OR2F1 GPR162 CHRM5 GRPR ADGRG4 | 1.05e-05 | 884 | 70 | 13 | GO:0004930 |
| GeneOntologyMolecularFunction | calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity | 3.63e-05 | 3 | 70 | 2 | GO:0048101 | |
| GeneOntologyMolecularFunction | calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity | 3.63e-05 | 3 | 70 | 2 | GO:0004117 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ADORA2A ADRA1A GPR19 OR6B3 OR1I1 APLNR PKD1 OR2C3 FCRL5 ADGRV1 OR2F1 GPR162 CHRM5 GRPR ADGRG4 | 5.64e-05 | 1353 | 70 | 15 | GO:0004888 |
| GeneOntologyMolecularFunction | ABC-type peptide transporter activity | 7.24e-05 | 4 | 70 | 2 | GO:0015440 | |
| GeneOntologyMolecularFunction | transporter activity | SFXN4 KCNT2 SLC12A4 GSDMD ABCB8 SLC22A11 SLC6A19 PKD1 SLC6A15 ATP10B SLC13A3 SLCO6A1 TAP2 CHRM5 | 1.30e-04 | 1289 | 70 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SFXN4 KCNT2 SLC12A4 GSDMD ABCB8 SLC22A11 SLC6A19 PKD1 SLC6A15 SLC13A3 SLCO6A1 TAP2 CHRM5 | 2.04e-04 | 1180 | 70 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 2.58e-04 | 477 | 70 | 8 | GO:0022804 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.94e-04 | 37 | 70 | 3 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.19e-04 | 38 | 70 | 3 | GO:0070001 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 3.75e-04 | 97 | 70 | 4 | GO:0008081 | |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 4.29e-04 | 9 | 70 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 5.97e-04 | 296 | 70 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.28e-03 | 230 | 70 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 1.79e-03 | 18 | 70 | 2 | GO:0015347 | |
| GeneOntologyMolecularFunction | symporter activity | 1.91e-03 | 150 | 70 | 4 | GO:0015293 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CD84 SFXN4 ADORA2A TCAF1 ADRA1A KCNT2 SLC12A4 MTOR ABCB8 SLC22A11 APLNR SLC6A19 PKD1 SLC6A15 SLC13A3 FCRL5 PLCH1 | 2.43e-06 | 1374 | 70 | 17 | GO:0006811 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | PRKD3 ADORA2A ADRA1A GPR19 OR6B3 OR1I1 APLNR OR2C3 AIPL1 SYP ADGRV1 OR2F1 GPR162 CHRM5 GRPR ADGRG4 AKAP12 | 2.99e-06 | 1395 | 70 | 17 | GO:0007186 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SFXN4 TCAF1 ADRA1A KCNT2 SLC12A4 MTOR ABCB8 APLNR SLC6A19 PKD1 SLC6A15 SLC13A3 FCRL5 PLCH1 | 1.89e-05 | 1115 | 70 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | metal ion transport | CD84 ADORA2A ADRA1A KCNT2 SLC12A4 ABCB8 APLNR SLC6A19 PKD1 SLC6A15 SLC13A3 FCRL5 PLCH1 | 2.74e-05 | 1000 | 70 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | regulation of protein kinase C signaling | 4.09e-05 | 20 | 70 | 3 | GO:0090036 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.15e-05 | 187 | 70 | 6 | GO:0007156 | |
| GeneOntologyBiologicalProcess | condensed mesenchymal cell proliferation | 6.78e-05 | 4 | 70 | 2 | GO:0072137 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CD84 ADORA2A ADRA1A KCNT2 SLC12A4 ABCB8 APLNR SLC6A19 PKD1 SLC6A15 SLC13A3 FCRL5 PLCH1 | 1.22e-04 | 1157 | 70 | 13 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ADRA1A KCNT2 SLC12A4 MTOR ABCB8 APLNR SLC6A19 PKD1 SLC6A15 SLC13A3 FCRL5 PLCH1 | 1.46e-04 | 1017 | 70 | 12 | GO:0098660 |
| GeneOntologyBiologicalProcess | digestion | 2.13e-04 | 160 | 70 | 5 | GO:0007586 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ADRA1A KCNT2 SLC12A4 ABCB8 APLNR SLC6A19 PKD1 SLC6A15 SLC13A3 FCRL5 PLCH1 | 2.59e-04 | 922 | 70 | 11 | GO:0098662 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | ADORA2A GAD2 MYOF ADRA1A SLC12A4 MTOR CNTNAP2 SYP BCHE CHRM5 AKAP12 | 2.81e-04 | 931 | 70 | 11 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | ADORA2A GAD2 MYOF ADRA1A SLC12A4 MTOR CNTNAP2 SYP BCHE CHRM5 AKAP12 | 2.81e-04 | 931 | 70 | 11 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | ADORA2A GAD2 MYOF ADRA1A SLC12A4 MTOR CNTNAP2 SYP BCHE CHRM5 AKAP12 | 3.03e-04 | 939 | 70 | 11 | GO:0099537 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ADRA1A KCNT2 SLC12A4 ABCB8 APLNR SLC6A19 PKD1 SLC6A15 SLC13A3 FCRL5 PLCH1 | 3.11e-04 | 942 | 70 | 11 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of monoatomic anion transmembrane transport | 3.14e-04 | 8 | 70 | 2 | GO:1903959 | |
| GeneOntologyBiologicalProcess | startle response | 3.64e-04 | 41 | 70 | 3 | GO:0001964 | |
| GeneOntologyBiologicalProcess | protein kinase C signaling | 3.64e-04 | 41 | 70 | 3 | GO:0070528 | |
| GeneOntologyBiologicalProcess | positive regulation of behavior | 4.19e-04 | 43 | 70 | 3 | GO:0048520 | |
| GeneOntologyBiologicalProcess | synaptic signaling | ADORA2A GAD2 MYOF ADRA1A SLC12A4 MTOR CNTNAP2 SYP BCHE CHRM5 AKAP12 | 4.20e-04 | 976 | 70 | 11 | GO:0099536 |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, GABAergic | 4.80e-04 | 45 | 70 | 3 | GO:0032228 | |
| GeneOntologyBiologicalProcess | regulation of gap junction assembly | 5.02e-04 | 10 | 70 | 2 | GO:1903596 | |
| GeneOntologyBiologicalProcess | amino acid transport | 5.28e-04 | 195 | 70 | 5 | GO:0006865 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 1.30e-06 | 7 | 71 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | late endosome lumen | 6.08e-06 | 11 | 71 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | endosome lumen | 4.20e-04 | 43 | 71 | 3 | GO:0031904 | |
| Domain | - | 1.49e-06 | 95 | 70 | 6 | 2.60.120.200 | |
| Domain | Aspartic_peptidase_N | 1.75e-06 | 7 | 70 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 1.75e-06 | 7 | 70 | 3 | PF07966 | |
| Domain | Aspartic_peptidase_A1 | 5.94e-06 | 10 | 70 | 3 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 5.94e-06 | 10 | 70 | 3 | IPR033121 | |
| Domain | Asp | 5.94e-06 | 10 | 70 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 5.94e-06 | 10 | 70 | 3 | PS51767 | |
| Domain | - | 1.08e-05 | 12 | 70 | 3 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 1.08e-05 | 12 | 70 | 3 | PS00141 | |
| Domain | Aspartic_peptidase_AS | 1.40e-05 | 13 | 70 | 3 | IPR001969 | |
| Domain | Peptidase_aspartic_dom | 3.30e-05 | 17 | 70 | 3 | IPR021109 | |
| Domain | GPCR_Rhodpsn_7TM | ADORA2A ADRA1A GPR19 OR6B3 OR1I1 APLNR OR2C3 OR2F1 GPR162 CHRM5 GRPR | 3.68e-05 | 670 | 70 | 11 | IPR017452 |
| Domain | 7tm_1 | ADORA2A ADRA1A GPR19 OR6B3 OR1I1 APLNR OR2C3 OR2F1 GPR162 CHRM5 GRPR | 4.04e-05 | 677 | 70 | 11 | PF00001 |
| Domain | PDEase_N | 4.14e-05 | 3 | 70 | 2 | IPR013706 | |
| Domain | PDEase_I_N | 4.14e-05 | 3 | 70 | 2 | PF08499 | |
| Domain | G_PROTEIN_RECEP_F1_1 | ADORA2A ADRA1A GPR19 OR6B3 OR1I1 APLNR OR2C3 OR2F1 GPR162 CHRM5 GRPR | 4.49e-05 | 685 | 70 | 11 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | ADORA2A ADRA1A GPR19 OR6B3 OR1I1 APLNR OR2C3 OR2F1 GPR162 CHRM5 GRPR | 4.86e-05 | 691 | 70 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | ADORA2A ADRA1A GPR19 OR6B3 OR1I1 APLNR OR2C3 OR2F1 GPR162 CHRM5 GRPR | 4.93e-05 | 692 | 70 | 11 | IPR000276 |
| Domain | Na/ntran_symport_orphan | 1.37e-04 | 5 | 70 | 2 | IPR002438 | |
| Domain | ConA-like_dom | 1.70e-04 | 219 | 70 | 6 | IPR013320 | |
| Domain | GPS | 2.78e-04 | 34 | 70 | 3 | SM00303 | |
| Domain | GPS | 3.03e-04 | 35 | 70 | 3 | PF01825 | |
| Domain | GPS | 3.29e-04 | 36 | 70 | 3 | PS50221 | |
| Domain | GPS | 3.58e-04 | 37 | 70 | 3 | IPR000203 | |
| Domain | LAM_G_DOMAIN | 3.87e-04 | 38 | 70 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 4.51e-04 | 40 | 70 | 3 | PF02210 | |
| Domain | LamG | 5.98e-04 | 44 | 70 | 3 | SM00282 | |
| Domain | Cadherin_CS | 7.48e-04 | 109 | 70 | 4 | IPR020894 | |
| Domain | 7TM_GPCR_Srsx | 8.29e-04 | 112 | 70 | 4 | SM01381 | |
| Domain | CADHERIN_1 | 8.57e-04 | 113 | 70 | 4 | PS00232 | |
| Domain | Cadherin | 8.57e-04 | 113 | 70 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 8.85e-04 | 114 | 70 | 4 | PS50268 | |
| Domain | - | 8.85e-04 | 114 | 70 | 4 | 2.60.40.60 | |
| Domain | CA | 9.15e-04 | 115 | 70 | 4 | SM00112 | |
| Domain | Cadherin-like | 9.45e-04 | 116 | 70 | 4 | IPR015919 | |
| Domain | Cadherin | 1.01e-03 | 118 | 70 | 4 | IPR002126 | |
| Domain | Laminin_G | 1.34e-03 | 58 | 70 | 3 | IPR001791 | |
| Domain | SNF | 2.27e-03 | 19 | 70 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 2.27e-03 | 19 | 70 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 2.27e-03 | 19 | 70 | 2 | PS50267 | |
| Domain | PDEase | 2.27e-03 | 19 | 70 | 2 | IPR023088 | |
| Domain | Na/ntran_symport | 2.27e-03 | 19 | 70 | 2 | IPR000175 | |
| Domain | FA58C | 2.78e-03 | 21 | 70 | 2 | SM00231 | |
| Domain | PDEase_I | 2.78e-03 | 21 | 70 | 2 | PF00233 | |
| Domain | FA58C_3 | 2.78e-03 | 21 | 70 | 2 | PS50022 | |
| Domain | PDEASE_I | 2.78e-03 | 21 | 70 | 2 | PS00126 | |
| Domain | PDEase_CS | 2.78e-03 | 21 | 70 | 2 | IPR023174 | |
| Domain | FA58C_1 | 2.78e-03 | 21 | 70 | 2 | PS01285 | |
| Domain | FA58C_2 | 2.78e-03 | 21 | 70 | 2 | PS01286 | |
| Domain | - | 3.05e-03 | 22 | 70 | 2 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 3.33e-03 | 23 | 70 | 2 | IPR002073 | |
| Domain | F5_F8_type_C | 3.62e-03 | 24 | 70 | 2 | PF00754 | |
| Domain | HDc | 3.62e-03 | 24 | 70 | 2 | SM00471 | |
| Domain | HD/PDEase_dom | 3.62e-03 | 24 | 70 | 2 | IPR003607 | |
| Domain | FA58C | 3.62e-03 | 24 | 70 | 2 | IPR000421 | |
| Domain | ABC_membrane | 3.62e-03 | 24 | 70 | 2 | PF00664 | |
| Domain | ABC_TM1F | 4.91e-03 | 28 | 70 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 4.91e-03 | 28 | 70 | 2 | IPR011527 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 6.53e-06 | 30 | 58 | 4 | M27566 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.04e-05 | 260 | 58 | 8 | M39397 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 1.07e-05 | 11 | 58 | 3 | M39726 | |
| Pathway | WP_GPCRS_OTHER | 3.90e-05 | 93 | 58 | 5 | M39629 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 8.66e-05 | 57 | 58 | 4 | M39812 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 8.75e-05 | 178 | 58 | 6 | M2890 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 2.47e-04 | 6 | 58 | 2 | MM14494 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 3.90e-04 | 84 | 58 | 4 | M27334 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 5.07e-04 | 90 | 58 | 4 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 5.28e-04 | 91 | 58 | 4 | M39426 | |
| Pathway | KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM | 7.33e-04 | 10 | 58 | 2 | M12882 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 9.86e-04 | 186 | 58 | 5 | MM15994 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 3017318 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 8.15e-09 | 3 | 71 | 3 | 21989121 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 9855083 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 9797498 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 2478370 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 8.15e-09 | 3 | 71 | 3 | 10675278 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 7926498 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 3780036 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 9561228 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 21455714 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 19800305 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 2901984 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 8.15e-09 | 3 | 71 | 3 | 3839486 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 24170207 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 3467902 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 4586732 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 8.15e-09 | 3 | 71 | 3 | 3014868 | |
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 8.15e-09 | 3 | 71 | 3 | 2892778 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 24383519 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 8.15e-09 | 3 | 71 | 3 | 2831884 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 8.15e-09 | 3 | 71 | 3 | 2799289 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 8.15e-09 | 3 | 71 | 3 | 1968039 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 2032552 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 8053437 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 1812762 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 7923573 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 8.15e-09 | 3 | 71 | 3 | 2566575 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 8.15e-09 | 3 | 71 | 3 | 12588289 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 8.15e-09 | 3 | 71 | 3 | 2229438 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 8.15e-09 | 3 | 71 | 3 | 19890696 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 8.15e-09 | 3 | 71 | 3 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 8.15e-09 | 3 | 71 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 8.15e-09 | 3 | 71 | 3 | 1956484 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 8540382 | ||
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 8.15e-09 | 3 | 71 | 3 | 8244094 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 21407214 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 8.15e-09 | 3 | 71 | 3 | 20981206 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 6774973 | ||
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 8.15e-09 | 3 | 71 | 3 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 8.15e-09 | 3 | 71 | 3 | 21970995 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 8.15e-09 | 3 | 71 | 3 | 22304859 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 24004680 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 8038355 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 20428942 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 8.15e-09 | 3 | 71 | 3 | 2227273 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 9525001 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 7886402 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 23034090 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 24125879 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 17379991 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 8.15e-09 | 3 | 71 | 3 | 3554488 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 21547904 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 23521833 | ||
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 3.26e-08 | 4 | 71 | 3 | 23047493 | |
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 3.26e-08 | 4 | 71 | 3 | 11915945 | |
| Pubmed | 3.26e-08 | 4 | 71 | 3 | 8322031 | ||
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 3.26e-08 | 4 | 71 | 3 | 17136346 | |
| Pubmed | 3.26e-08 | 4 | 71 | 3 | 12698190 | ||
| Pubmed | 8.13e-08 | 5 | 71 | 3 | 22066020 | ||
| Pubmed | 2.84e-07 | 7 | 71 | 3 | 16059920 | ||
| Pubmed | Crystal structure of human pepsin and its complex with pepstatin. | 4.11e-06 | 2 | 71 | 2 | 7663352 | |
| Pubmed | Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair? | 4.11e-06 | 2 | 71 | 2 | 17102641 | |
| Pubmed | Slow-wave sleep is controlled by a subset of nucleus accumbens core neurons in mice. | 4.11e-06 | 2 | 71 | 2 | 28963505 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 2714789 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 3197840 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 24882582 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 15003449 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 2415509 | ||
| Pubmed | Stage and cell-specific expression of calmodulin-dependent phosphodiesterases in mouse testis. | 4.11e-06 | 2 | 71 | 2 | 11369604 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 31504625 | ||
| Pubmed | 6.51e-06 | 18 | 71 | 3 | 36057966 | ||
| Pubmed | Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development. | 6.51e-06 | 18 | 71 | 3 | 33108146 | |
| Pubmed | 1.22e-05 | 22 | 71 | 3 | 38736483 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 31251475 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 31874168 | ||
| Pubmed | mTOR and differential activation of mitochondria orchestrate neutrophil chemotaxis. | 1.23e-05 | 3 | 71 | 2 | 26416965 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 9003415 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 2515193 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 18335582 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 7568196 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 26931735 | ||
| Pubmed | Regulated vesicular trafficking of specific PCDH15 and VLGR1 variants in auditory hair cells. | 1.23e-05 | 3 | 71 | 2 | 23035094 | |
| Pubmed | Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes. | 1.23e-05 | 3 | 71 | 2 | 17726023 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 21190592 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 33009420 | ||
| Pubmed | Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. | 2.46e-05 | 4 | 71 | 2 | 18463160 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 19255143 | ||
| Pubmed | Role for a novel Usher protein complex in hair cell synaptic maturation. | 2.46e-05 | 4 | 71 | 2 | 22363448 | |
| Pubmed | The inherited blindness protein AIPL1 regulates the ubiquitin-like FAT10 pathway. | 4.09e-05 | 5 | 71 | 2 | 22347407 | |
| Pubmed | Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2. | 4.09e-05 | 5 | 71 | 2 | 16301216 | |
| Pubmed | Multiple roles of epithelial heparan sulfate in stomach morphogenesis. | 5.09e-05 | 35 | 71 | 3 | 29700203 | |
| Pubmed | 5.72e-05 | 200 | 71 | 5 | 18240029 | ||
| Cytoband | 7q35 | 8.78e-05 | 55 | 71 | 3 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 1.51e-04 | 66 | 71 | 3 | chr7q35 | |
| GeneFamily | Cadherin related | 1.64e-07 | 17 | 54 | 4 | 24 | |
| GeneFamily | ATP binding cassette subfamily B | 4.73e-04 | 11 | 54 | 2 | 806 | |
| GeneFamily | Solute carriers | 1.12e-03 | 395 | 54 | 6 | 752 | |
| GeneFamily | Phosphodiesterases | 2.32e-03 | 24 | 54 | 2 | 681 | |
| Coexpression | GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP | 1.42e-05 | 193 | 71 | 6 | M3247 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_MAC_DN | 1.59e-05 | 197 | 71 | 6 | M5161 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-10 | 184 | 71 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-10 | 184 | 71 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-10 | 184 | 71 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-08 | 169 | 71 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-08 | 199 | 71 | 7 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-08 | 199 | 71 | 7 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.43e-07 | 149 | 71 | 6 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-07 | 160 | 71 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-07 | 160 | 71 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.82e-07 | 176 | 71 | 6 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-07 | 182 | 71 | 6 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.79e-07 | 189 | 71 | 6 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.89e-06 | 139 | 71 | 5 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.07e-06 | 149 | 71 | 5 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.07e-06 | 149 | 71 | 5 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.93e-06 | 155 | 71 | 5 | 99e749f7075e2c64e9a0bf91009f95b6969197c8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.93e-06 | 155 | 71 | 5 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-06 | 160 | 71 | 5 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.11e-06 | 162 | 71 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.09e-06 | 167 | 71 | 5 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 173 | 71 | 5 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 173 | 71 | 5 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_GRIP2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-06 | 175 | 71 | 5 | 0c648e7f67ffbe3b476a2ca77d246554f8cd1882 | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 9.14e-06 | 176 | 71 | 5 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 183 | 71 | 5 | 9d5a363fbe6f0a1668c9d584df65ee1c283349c7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 183 | 71 | 5 | c5caac6ed6c8d67f5c336281d9fd903976509445 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-05 | 185 | 71 | 5 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 187 | 71 | 5 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.29e-05 | 189 | 71 | 5 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 191 | 71 | 5 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 191 | 71 | 5 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-05 | 192 | 71 | 5 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-05 | 193 | 71 | 5 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 196 | 71 | 5 | 34e79918a448f6c19b87e1b1ce13c012b24be1f8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 196 | 71 | 5 | 8f82e01ca50aa4cd6149547505b4474a02fad618 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-05 | 197 | 71 | 5 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.65e-05 | 199 | 71 | 5 | b2508bf591720830e8e3494b1337aab14539956d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.69e-05 | 200 | 71 | 5 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.69e-05 | 200 | 71 | 5 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.69e-05 | 200 | 71 | 5 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.69e-05 | 200 | 71 | 5 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.69e-05 | 200 | 71 | 5 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.69e-05 | 200 | 71 | 5 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-05 | 200 | 71 | 5 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.69e-05 | 200 | 71 | 5 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.69e-05 | 200 | 71 | 5 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-05 | 200 | 71 | 5 | a1ae299cf77580a6d1a728ee591888b6d70a19d6 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.63e-05 | 124 | 71 | 4 | 36dfc702a570e1a1a6dde09f38badf9023ea7287 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.28e-05 | 144 | 71 | 4 | 7de962346ba9653d90dd13bb7d977fe44d200bba | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.20e-05 | 148 | 71 | 4 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-05 | 150 | 71 | 4 | 1270f33f9d7e46e55adf1a96e8beee858b95589d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-05 | 150 | 71 | 4 | 156118ce1d69522624196410cba18b8354cd0bb4 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-04 | 152 | 71 | 4 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.04e-04 | 57 | 71 | 3 | 9614fe2acc6ee039383504f94bbe6d35aac27f25 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.04e-04 | 57 | 71 | 3 | 309b3d48bfe215d7b581722c06d444b5b2ef6a30 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.04e-04 | 57 | 71 | 3 | 3c55a5598a7ea789500f2fbd35c79d2b97a3fc7d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.05e-04 | 153 | 71 | 4 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.10e-04 | 155 | 71 | 4 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 162 | 71 | 4 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 162 | 71 | 4 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 163 | 71 | 4 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 163 | 71 | 4 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-04 | 164 | 71 | 4 | d6f71d804bb65301c02ea4e6673e20688b5fcd5b | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-04 | 165 | 71 | 4 | 23955e3373660f827518e723ac62fba99753f375 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 167 | 71 | 4 | 713899690e4acd9d259645e363c26983d6ef3022 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 167 | 71 | 4 | d30b96c39da3dd02500443877a4eb3500e26802c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-04 | 168 | 71 | 4 | 2eed7dc1a2aff11be024823c4323c42bc94362f6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 168 | 71 | 4 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 169 | 71 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.60e-04 | 171 | 71 | 4 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-04 | 171 | 71 | 4 | 9e00c8191ca9d52151a49baf39f8581cb176fb76 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.64e-04 | 172 | 71 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.64e-04 | 172 | 71 | 4 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue | 1.64e-04 | 172 | 71 | 4 | 2cb2dc7cfd6db5a98a393b1a84c23abf3d692a53 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-04 | 173 | 71 | 4 | 75e26a65071b0d2f30ed0b2aa9859c488f5cf362 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-04 | 173 | 71 | 4 | 26e2e674f5d312fa8f61c11b553dc6101f063b16 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.72e-04 | 174 | 71 | 4 | a5f2a4e3b25e6084bd7003a53da86a44f6fcf294 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-04 | 174 | 71 | 4 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-04 | 175 | 71 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-04 | 175 | 71 | 4 | 8362a46f5804333baa84cd56d450bc147f372a7e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-04 | 175 | 71 | 4 | 06af6629766e2054e6995e8cdb3907658fec49d3 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-04 | 175 | 71 | 4 | 8b4c62e608f0ec84e563bbf0ebffe3ed44085298 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 175 | 71 | 4 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.75e-04 | 175 | 71 | 4 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-04 | 176 | 71 | 4 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.79e-04 | 176 | 71 | 4 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 177 | 71 | 4 | 2b675840b7d2bb536c2c600936733bd9e97e7120 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 177 | 71 | 4 | 5e0fca9bd5e5ffe6d39f5bcd81f36512f3b0cb1b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 177 | 71 | 4 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 177 | 71 | 4 | 62f180d5a487b449f715de49ee1e1e11c4e0cf4d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-04 | 177 | 71 | 4 | 43dce527392f3b8364bb6a55268ce9d6518d3a29 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-04 | 178 | 71 | 4 | 4b3ea0921bc598ebb9f63780ecdf8ad4349f3666 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 1.87e-04 | 178 | 71 | 4 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.87e-04 | 178 | 71 | 4 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-04 | 179 | 71 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.91e-04 | 179 | 71 | 4 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-04 | 179 | 71 | 4 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-04 | 179 | 71 | 4 | ec1d7017da325647b629de703135a404bbdc627d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-04 | 179 | 71 | 4 | 0b6731d9554f8bed1899c165a50e6b329ea19a6d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-04 | 180 | 71 | 4 | 7d3d5608647b6e684e8e185993d106a38c53e76a | |
| Drug | N-methyl-DL-aspartic acid | PRKD3 ADORA2A GAD2 ADRA1A MTOR ABCB8 BAAT PKD1 SYP BCHE ADGRV1 TAP2 | 7.89e-07 | 655 | 71 | 12 | CID000004376 |
| Drug | fluridone | 5.79e-06 | 82 | 71 | 5 | CID000043079 | |
| Drug | Fm 4-64 | 9.14e-06 | 90 | 71 | 5 | CID002733635 | |
| Drug | acetylcholine | 1.65e-05 | 361 | 71 | 8 | CID000000187 | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.93e-05 | 191 | 71 | 6 | 3392_UP | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 3968_DN | |
| Drug | sodium | PRKD3 KCNT2 SLC12A4 MTOR ABCB8 PKD1 CNTNAP2 SLC6A15 BCHE SLC13A3 TAP2 ARF6 | 3.23e-05 | 944 | 71 | 12 | CID000000923 |
| Drug | Repaglinide [135062-02-1]; Down 200; 8.8uM; HL60; HT_HG-U133A | 3.30e-05 | 195 | 71 | 6 | 6135_DN | |
| Drug | Ethylnitrosourea | 3.43e-05 | 291 | 71 | 7 | ctd:D005038 | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 3752_DN | |
| Drug | Procainamide hydrochloride [614-39-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 5663_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; HL60; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 2369_UP | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 4751_UP | |
| Drug | pyrachlostrobin | CD84 ADORA2A MYOF LIPA SLC12A4 AEBP1 TPP1 BCHE ADGRV1 TAP2 AKAP12 | 3.98e-05 | 811 | 71 | 11 | ctd:C513428 |
| Drug | BP 897 | 4.29e-05 | 22 | 71 | 3 | CID003038494 | |
| Drug | carbachol | 5.21e-05 | 688 | 71 | 10 | CID000002551 | |
| Drug | Dipivefrin | 5.73e-05 | 4 | 71 | 2 | DB00449 | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 3.32e-05 | 4 | 70 | 2 | DOID:898 (is_implicated_in) | |
| Disease | Hyperkinesia, Generalized | 6.04e-05 | 32 | 70 | 3 | C0751217 | |
| Disease | Hyperkinesia | 6.04e-05 | 32 | 70 | 3 | C3887506 | |
| Disease | Cocaine Abuse | 2.41e-04 | 127 | 70 | 4 | C0009171 | |
| Disease | adseverin measurement | 2.47e-04 | 10 | 70 | 2 | EFO_0801358 | |
| Disease | Major Depressive Disorder | 2.85e-04 | 243 | 70 | 5 | C1269683 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to methazolamide | 3.01e-04 | 11 | 70 | 2 | EFO_0004276, EFO_0004775, EFO_0020996 | |
| Disease | response to calcium channel blocker | 3.24e-04 | 56 | 70 | 3 | EFO_0007767 | |
| Disease | Cocaine Dependence | 3.40e-04 | 139 | 70 | 4 | C0600427 | |
| Disease | Unipolar Depression | 3.81e-04 | 259 | 70 | 5 | C0041696 | |
| Disease | susceptibility to hepatitis A infection measurement | 5.74e-04 | 68 | 70 | 3 | EFO_0008415 | |
| Disease | epilepsy (implicated_via_orthology) | 6.20e-04 | 163 | 70 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 6.52e-04 | 16 | 70 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 1.10e-03 | 85 | 70 | 3 | DOID:9744 (is_implicated_in) | |
| Disease | Nystagmus | 1.13e-03 | 21 | 70 | 2 | HP_0000639 | |
| Disease | Schizophrenia | 1.14e-03 | 883 | 70 | 8 | C0036341 | |
| Disease | gout | 1.23e-03 | 196 | 70 | 4 | EFO_0004274 | |
| Disease | colorectal carcinoma (is_implicated_in) | 1.24e-03 | 22 | 70 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | sorbitol measurement | 1.36e-03 | 23 | 70 | 2 | EFO_0010533 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 1.61e-03 | 97 | 70 | 3 | EFO_0007878, EFO_0009458 | |
| Disease | Disorder of eye | 1.64e-03 | 212 | 70 | 4 | C0015397 | |
| Disease | methionine measurement | 1.74e-03 | 26 | 70 | 2 | EFO_0009771 | |
| Disease | serum metabolite measurement | 1.75e-03 | 945 | 70 | 8 | EFO_0005653 | |
| Disease | Visual seizure | 1.80e-03 | 101 | 70 | 3 | C0270824 | |
| Disease | Epileptic drop attack | 1.80e-03 | 101 | 70 | 3 | C0270846 | |
| Disease | Generalized seizures | 1.80e-03 | 101 | 70 | 3 | C0234533 | |
| Disease | Clonic Seizures | 1.80e-03 | 101 | 70 | 3 | C0234535 | |
| Disease | Vertiginous seizure | 1.80e-03 | 101 | 70 | 3 | C0422855 | |
| Disease | Gustatory seizure | 1.80e-03 | 101 | 70 | 3 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.80e-03 | 101 | 70 | 3 | C0422850 | |
| Disease | Olfactory seizure | 1.80e-03 | 101 | 70 | 3 | C0422853 | |
| Disease | Seizures, Auditory | 1.80e-03 | 101 | 70 | 3 | C0422852 | |
| Disease | Generalized Absence Seizures | 1.80e-03 | 101 | 70 | 3 | C4505436 | |
| Disease | Convulsive Seizures | 1.80e-03 | 101 | 70 | 3 | C0751494 | |
| Disease | Seizures, Sensory | 1.80e-03 | 101 | 70 | 3 | C0751496 | |
| Disease | Jacksonian Seizure | 1.80e-03 | 101 | 70 | 3 | C0022333 | |
| Disease | Non-epileptic convulsion | 1.80e-03 | 101 | 70 | 3 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.80e-03 | 101 | 70 | 3 | C0751123 | |
| Disease | Complex partial seizures | 1.80e-03 | 101 | 70 | 3 | C0149958 | |
| Disease | Single Seizure | 1.80e-03 | 101 | 70 | 3 | C0751110 | |
| Disease | Epileptic Seizures | 1.80e-03 | 101 | 70 | 3 | C4317109 | |
| Disease | Nonepileptic Seizures | 1.80e-03 | 101 | 70 | 3 | C3495874 | |
| Disease | Tonic Seizures | 1.86e-03 | 102 | 70 | 3 | C0270844 | |
| Disease | Absence Seizures | 1.86e-03 | 102 | 70 | 3 | C4316903 | |
| Disease | Convulsions | 1.86e-03 | 102 | 70 | 3 | C4048158 | |
| Disease | Seizures, Focal | 1.96e-03 | 104 | 70 | 3 | C0751495 | |
| Disease | Myoclonic Seizures | 1.96e-03 | 104 | 70 | 3 | C4317123 | |
| Disease | Tonic - clonic seizures | 1.96e-03 | 104 | 70 | 3 | C0494475 | |
| Disease | Toxic Encephalitis | 2.16e-03 | 29 | 70 | 2 | C0154659 | |
| Disease | Neurotoxicity Syndromes | 2.16e-03 | 29 | 70 | 2 | C0235032 | |
| Disease | abdominal:gluteofemoral adipose tissue ratio measurement | 2.16e-03 | 29 | 70 | 2 | EFO_0803320 | |
| Disease | Encephalopathy, Toxic | 2.16e-03 | 29 | 70 | 2 | C0149504 | |
| Disease | Ciliopathies | 2.30e-03 | 110 | 70 | 3 | C4277690 | |
| Disease | malate measurement | 2.31e-03 | 30 | 70 | 2 | EFO_0010508 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 2.31e-03 | 30 | 70 | 2 | EFO_0000341, EFO_0004351 | |
| Disease | Glioblastoma Multiforme | 2.36e-03 | 111 | 70 | 3 | C1621958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTATVLINGTNFPFG | 251 | Q14032 | |
| LTVFGGTVTAFLGIP | 46 | P06276 | |
| TGELPNFITGSRVIF | 21 | Q9NZN9 | |
| LTSFPTFTSVGVLIV | 41 | Q9HC47 | |
| LSPEFFTSVVQGVLS | 696 | P46379 | |
| GVLAIPFAITISTGF | 56 | P29274 | |
| GIVTPFVGTTAFSPL | 1666 | Q8IZF6 | |
| FTQGKVVGQTTPESF | 1106 | Q02952 | |
| EIATGQAFPFTTVET | 1136 | Q8IUX7 | |
| TSTVLPFSAIFEVLG | 76 | P35348 | |
| EFIPVTSLQSSTGFQ | 21 | P57764 | |
| VASTPFVLLQFTTGR | 116 | Q15760 | |
| FVIDPNTGVITTQGF | 3241 | Q6V0I7 | |
| FTQDVFPVQGTVVFG | 936 | Q8WXG9 | |
| IFPTSGVILFTEGQV | 3701 | Q8WXG9 | |
| DVTGQFPSSFVEIVT | 46 | Q6XZF7 | |
| DIDVFTFGTPINTIS | 1221 | O94823 | |
| PSSFFIVVQTGLGLQ | 521 | Q9HC84 | |
| GIGTPAQDFTVVFDT | 81 | P0DJD9 | |
| LGVSSTTVGFVVPFT | 201 | P35414 | |
| VGVQPATGEVVFDSF | 391 | P20585 | |
| GFVPFLVSATAGTTV | 326 | Q05329 | |
| DSLTGVPILVVSFFS | 281 | Q16538 | |
| FTTDFKTGVLTVTGP | 2216 | Q9NYQ8 | |
| GFGPQRSEVVSLFVT | 546 | Q96RD9 | |
| SQIGFIDFIVEPTFS | 416 | P54750 | |
| SQVGFIDFIVEPTFT | 426 | Q14123 | |
| IFLTTGIVVSAFGLP | 71 | O95214 | |
| SVGVIIYVSLSGTFP | 761 | O94806 | |
| PLISVSGVSQGFEFL | 121 | Q9H0R1 | |
| CIVTFSTVGFGDVTP | 236 | Q6UVM3 | |
| ELVIFAFGIVVGTSP | 196 | O60431 | |
| SGFISSPVQTAITFQ | 151 | Q13607 | |
| NVSSPEVFVLLGFST | 6 | Q8N628 | |
| GIGTPAQDFTVVFDT | 81 | P0DJD8 | |
| VNVSFSSEGTPLAVF | 2976 | Q6V1P9 | |
| VNELTPVGTTIFTGF | 156 | Q96QU1 | |
| ELPTFTGVLFNTVGL | 391 | Q5JV73 | |
| IPFIQLTSVGVSVFT | 116 | P30550 | |
| TVFEGFTEGELTFQP | 566 | P32019 | |
| VSFSFDVGNGPVEIV | 856 | Q9UHC6 | |
| SISGSRFVGPFLQTV | 1446 | Q8IVF4 | |
| AVAGTSTIFAPTFVI | 181 | Q9NSA0 | |
| TGVAIVTILFFFPSQ | 381 | Q8WWT9 | |
| VFVVSFGDTPLTQSI | 2231 | P98161 | |
| GIGTPAQDFTVVFDT | 81 | P0DJD7 | |
| VGFISQEPVLFGTTI | 551 | Q9NUT2 | |
| TVPAVQGFFRSISLS | 1881 | P42345 | |
| PVTSGLNTSVVFGFL | 196 | P08247 | |
| GATNGIVFLFTPNVT | 246 | Q695T7 | |
| FGTIEGIVTPIVDTF | 476 | Q9H2J7 | |
| VSPEAVGFLSAVGVF | 21 | Q8NB59 | |
| AVASSTFLGVIPQFV | 171 | Q6P4A7 | |
| VLFTFPGNLVTSVAG | 166 | Q9Y4C2 | |
| GVKTFNFPETVFTTV | 266 | Q96SF7 | |
| IFTVNGILGESVTFP | 26 | Q9UIB8 | |
| FSTLIFSGFSGVPIV | 586 | Q86UG4 | |
| VVSVGQEPVLFSGSV | 546 | Q03519 | |
| VTRVGTFILVGFPTA | 6 | Q8NGW1 | |
| IATSFTVLVGIFFPS | 416 | Q9UP95 | |
| IIIGAFFIPEGTFTT | 136 | Q9NRX5 | |
| QFLSEPTITFGTAIA | 186 | P08912 | |
| GQSVTTIPTVGFNVE | 36 | P62330 | |
| QQITVISPFSFSIGD | 261 | A0AVT1 | |
| TFIFGVPASSGTVVS | 1816 | Q8IZQ1 | |
| FTAPATVSLVGVTVF | 296 | Q71RG4 | |
| TEITIRGFGFSTIPA | 1346 | Q86WI1 | |
| FVGQRTVTFSSLVPG | 821 | Q4KWH8 | |
| SEGFIPLTFTATQEI | 656 | Q9H6R7 | |
| TTVGGTSFQEPFLIT | 386 | O14773 | |
| GTTIGFIAFSQIPEL | 176 | P38571 | |
| VNTGETEVGFVPTFG | 486 | Q9NZM1 |